NEW YORK, April 30 - AxCell Biosciences said today that it will collaborate with Mount Sinai School of Medicine researcher Irwin Gelman to study HIV-assocated nephropathy.
The research seeks to identify new treatments for the disease. It is the second partnership between AxCell and Mount Sinai.
Under the agreement, AxCell will provide its expertise in signal transduction analysis to find molecules that inhibit interactions between cellular proteins and HIV proteins. Lead molecules will be tested in cell culture and with transgenic mice.
The company has an option to negotiate exclusive, worldwide, royalty-bearing licenses from the medical school for any inventions developed in this collaboration.
Incidence of HIV-related nephropathy is on the rise, as patients treated with antiretrovirals live longer.